- Home
- KALV vs CLMB Comparison
KALV vs CLMB Comparison
Compare KALV & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- CLMB
- Stock Information
- Founded
- KALV N/A
- CLMB 1982
- Country
- KALV United States
- CLMB United States
- Employees
- KALV N/A
- CLMB N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- CLMB Retail: Computer Software & Peripheral Equipment
- Sector
- KALV Health Care
- CLMB Technology
- Exchange
- KALV Nasdaq
- CLMB Nasdaq
- Market Cap
- KALV 563.1M
- CLMB 457.3M
- IPO Year
- KALV N/A
- CLMB N/A
- Fundamental
- Price
- KALV $12.00
- CLMB $106.47
- Analyst Decision
- KALV Strong Buy
- CLMB Buy
- Analyst Count
- KALV 8
- CLMB 1
- Target Price
- KALV $24.83
- CLMB $136.00
- AVG Volume (30 Days)
- KALV 729.1K
- CLMB 29.0K
- Earning Date
- KALV 03-12-2025
- CLMB 04-30-2025
- Dividend Yield
- KALV N/A
- CLMB 0.64%
- EPS Growth
- KALV N/A
- CLMB 49.27
- EPS
- KALV N/A
- CLMB 4.06
- Revenue
- KALV N/A
- CLMB $465,607,000.00
- Revenue This Year
- KALV N/A
- CLMB $7.10
- Revenue Next Year
- KALV N/A
- CLMB $8.00
- P/E Ratio
- KALV N/A
- CLMB $26.22
- Revenue Growth
- KALV N/A
- CLMB 32.27
- 52 Week Low
- KALV $7.30
- CLMB $49.70
- 52 Week High
- KALV $15.50
- CLMB $145.00
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- CLMB 45.06
- Support Level
- KALV $11.42
- CLMB $104.34
- Resistance Level
- KALV $12.35
- CLMB $108.38
- Average True Range (ATR)
- KALV 0.96
- CLMB 5.74
- MACD
- KALV 0.04
- CLMB 0.73
- Stochastic Oscillator
- KALV 88.74
- CLMB 74.48
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.